BRIEF-Genmab enters commercial license agreement with Gilead for DuoBody(R)Technology
August 10, 2016 at 13:39 PM EDT
* Genmab enters commercial license agreement with Gilead for DuoBody(R) Technology
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.